Clinical Trials Directory

276 clinical trials found.
Skin, Hair and Nails

We are doing this study to find out if an experimental drug called BMS-986322 (the study drug) is a safe and effective option for people with moderate to severe psoriasis.

Compensation: Yes
Ages: 18-70
Non-Oncology
Other
Brain, Spinal Cord and Nerves

We created this healthy volunteer registry for people who would like to participate in brain imaging research studies. These studies use structural and functional MRI data to study areas of the brain associated with movement, memory, attention, and perception.

Compensation: Yes
Ages: 18-80
Non-Oncology
Duke University Hospital
Breast Cancer

We are doing this study to try and find a way to detect breast cancer earlier or before it recurs.

Compensation: No
Ages: 18-110
Oncology
Duke University Hospital
Breast Cancer

We are doing this study to learn more about breast cancer and how it develops.

Compensation: Yes
Ages: 18-100
Oncology
Duke University Hospital, Duke Regional Hospital
Heart and Circulation

We are doing this study to find out if an experimental drug called eplontersen (the study drug) is safe and helpful for people with cardiac amyloidosis. We are enrolling people who previously participated in a clinical trial for this drug called the CardioTTRansform study (ION-682884-CS2).

Compensation: No
Non-Oncology
Heart and Circulation

We are doing this study to see how different things, like medical and treatment history, affect outcomes in people with cardiac amyloidosis.

Compensation: No
Non-Oncology
Hematologic Malignancies and Cellular Therapy

We are doing this study to find out if an experimental drug called CAP-100 (study drug) is a safe and effective treatment for people who have CLL or SLL that is not responding to standard treatments. We also want to know what dose of this study drug works best.

Compensation: No
Oncology
Brain, Spinal Cord and Nerves

We are doing this study to find out if an experimental cell therapy called NRTX-1001 (the study drug) is a safe and effective treatment for drug-resistant mesial temporal lobe epilepsy (MTLE). We want to know if the study drug can reduce seizures in people who are not getting relief from conventional treatments.

Compensation: Yes
Ages: 18-65
Non-Oncology
Duke University Hospital